Improving Outcomes in Anaplastic Lymphocyte Kinase-Positive Metastatic Non-Small Cell Lung Cancer
Cancer Therapy Advisor,
By Clinical Content Hub Among cancer types, lung cancer is the most frequently diagnosed, having accounted for 11.4% of the…
By Clinical Content Hub Among cancer types, lung cancer is the most frequently diagnosed, having accounted for 11.4% of the…
The advent of next-generation sequencing (NGS) has been a key driver in treatment advances and improved outcomes for patients…
Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients…
미국 덴버, Jan. 25, 2018 (GLOBE NEWSWIRE) -- 폐암에 대한 분자진단 검사가 발전을 거듭함에 따라 새로운 치료법이 속속 개발되고 있다.
デンバー発, Jan. 25, 2018 (GLOBE NEWSWIRE) -- 肺癌の分子診断検査には急速な進歩があり、全世界における癌による死亡で占める率が最も高い肺癌で新しい治療の導入を実現し、患者に大きな希望をもたらしている。 このような進歩について…
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new…
GlobeNewswire 2018-01-23 DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of…
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new…
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new…
Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer DENVER, Jan.
Denver, CO, January 23, 2018--Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments…